Announced Fri, 10 Jul · 20:25 IST
Orchid Pharma-Dhanuka Labs amalgamation scheme effective; share swap ratio fixed
General View source PDF
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.9%1-day move
₹1008.45
prior close
₹1009.05
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4-0.8-0.0+0.0+4.9+9.2+6.8+2.9+3.8-0.8————
Up moveDown movePending
AI summary
Orchid Pharma's amalgamation scheme with Dhanuka Laboratories became effective July 10, 2026 with appointed date April 1, 2024. Dhanuka Labs dissolved without winding up. Authorized share capital rose to Rs 164.51 crore (16.45 crore equity shares of Rs 10 each). Record date for eligible Dhanuka shareholders set at July 23, 2026. Share swap ratio: 161 OPL shares for every 5 Dhanuka shares.
Likely market impact
Dhanuka Labs shareholders to receive 161 OPL shares per 5 DLL shares. Dhanuka Labs now dissolved. Orchid Pharma's capital base expands.